Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVLA
11276
CALL
Palvella Therapeutics
PVLA
$2.25B
| $93K | ﹤0.01% |
1,191
+250
| +27% | +$28.9K |
|
|
CGRN
11277
CALL
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $93K | ﹤0.01% |
69,900
+54,900
| +366% | +$96.6K |
|
11278
Orion Group Holdings
ORN
$402M
| $92.8K | ﹤0.01% |
35,815
+3,946
| +12% | +$11K |
|
11279
CALL
Dream Finders Homes
DFH
$1.42B
| $92.8K | ﹤0.01% |
7,000
+4,200
| +150% | +$49.6K |
|
|
VIOT
11280
Viomi Technology
VIOT
$47.2M
| $92.7K | ﹤0.01% |
90,042
+14,681
| +19% | +$17.9K |
|
|
MGIC
11281
PUT
DELISTED
Magic Software Enterprises
MGIC
| $92.7K | ﹤0.01% |
6,800
-40,400
| -86% | -$615K |
|
11282
PUT
Northwest Bancshares
NWBI
$2.31B
| $92.6K | ﹤0.01% |
7,700
+1,300
| +20% | +$17.6K |
|
11283
PUT
Quanex
NX
$962M
| $92.6K | ﹤0.01% |
4,300
+4,100
| +2,050% | +$98.4K |
|
11284
iShares MSCI Malaysia ETF
EWM
$330M
| $92.5K | ﹤0.01% |
+4,171
| New | +$94.3K |
|
|
INBX
11285
PUT
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $92.5K | ﹤0.01% |
4,900
-2,600
| -35% | -$60.5K |
|
|
QQQH
11286
CALL
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$387M
| $92.4K | ﹤0.01% |
2,350
-16,300
| -87% | -$623K |
|
11287
CALL
Unisys
UIS
$209M
| $92.3K | ﹤0.01% |
23,800
-16,100
| -40% | -$77.8K |
|
11288
CALL
C4 Therapeutics
CCCC
$522M
| $92.3K | ﹤0.01% |
29,400
+19,800
| +206% | +$117K |
|
11289
PUT
AirSculpt Technologies
AIRS
$247M
| $92.2K | ﹤0.01% |
+18,300
| New | +$101K |
|
11290
CALL
Theravance Biopharma
TBPH
$881M
| $92.2K | ﹤0.01% |
8,500
-40,100
| -83% | -$424K |
|
|
USBC
11291
USBC Inc
USBC
$149M
| $92.2K | ﹤0.01% |
+2,589
| New | +$121K |
|
11292
CALL
Kartoon Studios
TOON
$37.4M
| $92K | ﹤0.01% |
33,700
-9,800
| -23% | -$44.6K |
|
11293
PUT
Outset Medical
OM
$84.8M
| $92K | ﹤0.01% |
333
+146
| +78% | +$53.6K |
|
11294
CALL
ICL Group
ICL
$7.16B
| $91.8K | ﹤0.01% |
13,500
+1,800
| +15% | +$13.3K |
|
11295
CALL
CPS Technologies
CPSH
$83.6M
| $91.7K | ﹤0.01% |
32,300
-3,200
| -9% | -$9.23K |
|
11296
Extreme Networks
EXTR
$3.2B
| $91.7K | ﹤0.01% |
4,796
-24,798
| -84% | -$458K |
|
11297
CALL
Jakks Pacific
JAKK
$294M
| $91.7K | ﹤0.01% |
+5,300
| New | +$99.4K |
|
11298
PUT
MeiraGTx Holdings
MGTX
$1.3B
| $91.5K | ﹤0.01% |
17,700
+15,300
| +638% | +$106K |
|
11299
CALL
A10 Networks
ATEN
$1.99B
| $91.4K | ﹤0.01% |
5,900
-10,000
| -63% | -$153K |
|
11300
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
| $91.4K | ﹤0.01% |
37,600
+34,000
| +944% | +$77.9K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.